Aslan Pharmaceuticals (ASLN) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Aslan Pharmaceuticals has initiated voluntary liquidation for its main operating subsidiary after a strategic review, leading to the termination of all employees. The company, facing delisting from the Nasdaq due to non-compliance with listing requirements, has appointed Quantuma (Singapore) as the liquidator to explore strategic alternatives for its key assets, eblasakimab and farudodstat, while also preparing to liquidate under Cayman law.
For further insights into ASLN stock, check out TipRanks’ Stock Analysis page.
